Kristin Peck is CEO of Zoetis, the world’s leading animal health company, a Fortune 500 organization, with $7.8 billion in annual revenue and 12,100 employees worldwide. She is also a member of ...
Zoetis, whose CEO Kristin Peck was named to the CNBC Changemakers list on Wednesday, recently had the first monoclonal antibody pain treatment for cats and dogs approved. If you want to understand ...
Zoetis CEO Kristen Peck talks about expanding their line of medications and she says the market for animal care products is growing. Peck also says its arthritis drug for dogs, Librela ...
in.investing.com on MSN3mon
Zoetis lifts full-year guidance amid strength at companion animal unitIn a statement, Chief Executive Officer Kristin Peck said the group has retained a "relentless focus" on innovating new ...
Vaccine will help poultry producers and veterinarians fight rapidly emerging avian metapneumovirus in the United States ...
2025--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 13, 2025. Chief Executive Officer Kristin Peck and Executive Vice ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback